Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

<p><strong>Introduction:</strong> Less-invasive surfactant administration (LISA) is a method of surfactant delivery to preterm infants for treating respiratory distress syndrome (RDS), which can reduce the composite risk of death or bronchopulmonary dysplasia and the time on mechan...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Reynolds, P, Bustani, P, Darby, C, Fernandez Alvarez, JR, Fox, G, Jones, S, Robertson, SJ, Vasu, V, Roehr, CC
Format:	Journal article
Język:	English
Wydane:	Karger Publishers 2021

Podobne zapisy

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
od: Ramaswamy, VV, i wsp.
Wydane: (2021)

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
od: Ramaswamy, VV, i wsp.
Wydane: (2021)

To sedate or not to sedate for less invasive surfactant administration: an ethical approach
od: Peterson, J, i wsp.
Wydane: (2021)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
od: Breindahl, N, i wsp.
Wydane: (2023)

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus
od: Jing Liu, i wsp.
Wydane: (2025-02-01)

Efficacy of non‐invasive respiratory support modes for primary respiratory support in preterm neonates with Respiratory Distress Syndrome: Systematic review and network meta‐analysis
od: Ramaswamy, VV, i wsp.
Wydane: (2020)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
od: S. A. Perepelitsa, i wsp.
Wydane: (2009-10-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
od: Suada Heljić, i wsp.
Wydane: (2009-08-01)

Surfactant and respiratory distress syndrome
od: A D Milner
Wydane: (1996-01-01)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
od: Anna Tarocco, i wsp.
Wydane: (2015-01-01)

Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome
od: Espinosa, Frank F. (Frank Francis)
Wydane: (2005)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
od: Anna Tarocco, i wsp.
Wydane: (2015-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
od: S. A. Perepelitsa, i wsp.
Wydane: (2007-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
od: S. A. Perepelitsa
Wydane: (2014-08-01)

Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensus
od: Segundo Rite Gracia, i wsp.
Wydane: (2024-11-01)

Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome
od: Chutinun Wongkhonkaen, i wsp.
Wydane: (2023-05-01)

Clinical efficacy of using pulmonary surfactant at different times in the treatment of neonatal respiratory distress syndrome
od: ZHU Ling, i wsp.
Wydane: (2023-12-01)

An uncommon cause of neonatal respiratory distress
od: Gabriel Dimitriou, i wsp.
Wydane: (2010-12-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
od: İ.A. Mirzayeva, i wsp.
Wydane: (2024-04-01)

Exogenous surfactant therapy in non-respiratory distress syndrome
od: A Greenough
Wydane: (1996-01-01)

Surfactant BL-Induced Changes in Blood Gas Composition and Acid-Base Balance In Neonatal Respiratory Distress Syndrome
od: S. A. Perepelitsa, i wsp.
Wydane: (2006-08-01)

Laryngeal Mask Airway Method for Minimally Invasive Surfactant Therapy in Neonates with Pneumothorax Complicating Respiratory Distress Syndrome
od: Joaquim M. B. Pinheiro, i wsp.
Wydane: (2025-01-01)

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis
od: Moschino, L, i wsp.
Wydane: (2022)

Surfactant as a drug carrier
od: Sett, A, i wsp.
Wydane: (2023)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
od: Morteza Habibi, i wsp.
Wydane: (2024-01-01)

Guidelines on the management of acute respiratory distress syndrome
od: Danny Francis McAuley, i wsp.
Wydane: (2019-10-01)

The Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome Treated by Minimally Invasive Surfactant Therapy and Non-Invasive Ventilation
od: Tzyy-Rong Huang, i wsp.
Wydane: (2024-04-01)

Respiratory Distress and the Bacteria Causing Infection in the Neonates
od: Neihaya Heikmat Zaki
Wydane: (2012-06-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
od: Nilgün Köksal, i wsp.
Wydane: (2009-12-01)

Management of neonates with respiratory distress syndrome in resource-limited settings
od: Radhika Singh, i wsp.
Wydane: (2024-05-01)

INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate
od: Ali Naseh, i wsp.
Wydane: (2014-06-01)

Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome
od: Yupeng Lei, i wsp.
Wydane: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
od: Ozge Sürmeli-Onay, i wsp.
Wydane: (2012-06-01)

Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome
od: James F Lewis, i wsp.
Wydane: (1997-01-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
od: A. V. Vlasenko, i wsp.
Wydane: (2005-12-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
od: V. V. Moroz, i wsp.
Wydane: (2013-08-01)

The association between sex and neonatal respiratory distress syndrome
od: Keren Fang, i wsp.
Wydane: (2024-02-01)

Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants
od: Chamindu C. Gunatilaka, i wsp.
Wydane: (2024-09-01)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) – It is time to classify respiratory distress syndrome (RDS) in preterm neonates
od: Deepti Thandaveshwara, i wsp.
Wydane: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
od: Hassan Boskabadi, i wsp.
Wydane: (2024-10-01)